Earnings History Data for Horizon Therapeutics (HZNP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Horizon Therapeutics

Horizon Therapeutics PLC is a biopharmaceutical company. It is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines which address unmet medical needs. The Company markets medicines through its orphan, rheumatology and primary care business units. Horizon Therapeutics PLC, formerly known as Horizon Pharma Public Limited Company, is headquartered in Dublin, Ireland.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-05-2022	PM	7:00 AM ET (May 4)	HZNP	Horizon Therapeutics	22,587	1.34	1.27	0.00	Horizon Therapeutics Non-GAAP EPS of $1.34 beats by $0.20, revenue of $885.2M beats by $18.81M [5/4/2022 7:09 AM]	95.65	0.93 (0.98%)	89.00	-5.72 (-6.04%)	83.42 - 120.53	5,284,539	1,910,000	152,663
Horizon Therapeutics Q1 2022 Earnings Preview [5/3/2022 2:15 PM] Horizon Therapeutics says rheumatoid arthritis drug met main goal in mid-stage study [5/3/2022 9:37 AM] Horizon Therapeutics Non-GAAP EPS of $1.34 beats by $0.20, revenue of $885.2M beats by $18.81M [5/4/2022 7:09 AM] Are You a Value Investor? This 1 Stock Could Be the Perfect Pick [May-03-22 09:40AM] Topline Data for Dazodalibep (HZN-4920) Meets Primary Endpoint in Rheumatoid Arthritis [May-03-22 09:15AM] Horizon Therapeutics plc Reports First-Quarter 2022 Financial Results [May-04-22 07:00AM] HZNP or TECH: Which Is the Better Value Stock Right Now? [May-03-22 11:40AM]
01-03-2022	PM	7:00 AM ET (Mar 1)	HZNP	Horizon Therapeutics Public Limited Company	21,320	1.41	1.27	1.28	Horizon Therapeutics Non-GAAP EPS of $1.41 beats by $0.06, revenue of $1.01B beats by $14.1M; initiates FY22 guidance [3/1/2022 7:07 AM]	97.14	5.97 (6.54%)	95.00	3.83 (4.20%)	79.81 - 120.53	2,362,976	2,430,000	1,264
Horizon Therapeutics Q4 2021 Earnings Preview [2/28/2022 11:47 AM] Horizon Therapeutics Non-GAAP EPS of $1.41 beats by $0.06, revenue of $1.01B beats by $14.1M; initiates FY22 guidance [3/1/2022 7:07 AM] Horizon Therapeutics rises in premarket after earnings beat, 2022 guidance [3/1/2022 9:26 AM] Horizon Therapeutics plc Launches #RAREis Representation Program to Elevate Global Rare Disease Equity [Feb-28-22 11:29AM] Horizon Therapeutics plc Reports Fourth-Quarter 2021 and Full-Year 2021 Financial Results; Announces Full-Year 2022 Guidance [Mar-01-22 07:00AM]
03-11-2021	PM	7:00 AM ET (Nov 3)	HZNP	Horizon Therapeutics Public Limited Company	26,720	1.75	1.54	1.74	Horizon Therapeutics EPS beats by $0.21, beats on revenue [11/3/2021 7:04 AM]	116.40	-1.00 (-0.85%)	112.00	-5.40 (-4.60%)	66.41 - 120.53	2,448,057	1,860,000	26,314
Horizon Therapeutics Q3 2021 Earnings Preview [11/2/2021 12:04 PM] Horizon Therapeutics EPS beats by $0.21, beats on revenue [11/3/2021 7:04 AM] Horizon Therapeutics raises guidance; announces CFO succession [11/3/2021 9:25 AM] Horizon Therapeutics (HZNP) is a Top-Ranked Momentum Stock: Should You Buy? [Nov-02-21 10:00AM] Horizon Therapeutics plc Announces Chief Financial Officer Succession Plan [Nov-03-21 07:02AM] Horizon Therapeutics plc Reports Record Third-Quarter 2021 Financial Results; Increasing Full-Year 2021 Net Sales and Adjusted EBITDA Guidance [Nov-03-21 07:00AM] Horizon Pharma plc (HZNP) Q3 2021 Earnings Call Transcript [Nov-03-21 05:00PM] Horizon CEO: Growth Driver Tepezza 'Still At A Fraction' Of Expected Peak Sales [Nov-03-21 12:55PM]
04-08-2021	PM	7:00 AM ET (Aug 4)	HZNP	Horizon Therapeutics Public Limited Company	22,430	1.62	0.91	0.43	Horizon Therapeutics EPS beats by $0.75, beats on revenue [8/4/2021 7:08 AM]	107.51	7.75 (7.77%)	107.51	0.0 (0.00%)	60.82 - 111.33	4,138,832	1,370,000	25,727
Horizon Therapeutics Q2 2021 Earnings Preview [8/3/2021 1:01 PM] Horizon Therapeutics EPS beats by $0.75, beats on revenue [8/4/2021 7:08 AM] Horizon Therapeutics jumps 9% on Q2 beat; FY21 guidance raise tops consensus [8/4/2021 7:53 AM] Horizon Therapeutics plc Reports Record Second-Quarter 2021 Financial Results; Increasing Full-Year 2021 Net Sales and Adjusted EBITDA Guidance [Aug-04-21 07:00AM]
05-05-2021	PM	7:00 AM ET (May 5)	HZNP	Horizon Therapeutics Public Limited Company	21,210	0.03	0.07	0.44	Horizon Therapeutics EPS misses by $0.02, beats on revenue [5/5/2021 7:06 AM]	89.30	-1.43 (-1.58%)	89.30	0.0 (0.00%)	36.27 - 97.20	2,367,204	1,160,000	66,468
Horizon Therapeutics Q1 2021 Earnings Preview [5/4/2021 1:31 PM] Horizon Therapeutics EPS misses by $0.02, beats on revenue [5/5/2021 7:06 AM] Horizon updates full-year guidance to reflect Viela Bio acquisition [5/5/2021 9:01 AM] Was The Smart Money Right About Horizon Therapeutics (HZNP)? [May-04-21 01:59PM] Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc. [May-05-21 07:00AM] Is Horizon Therapeutics Public Limited Company (HZNP) A Smart Long-Term Buy? [May-05-21 12:53PM]
24-02-2021	PM	7:00 AM ET (Feb 24)	HZNP	Horizon Therapeutics Public Limited Company	18,490	1.28	1.05	0.56	Horizon Therapeutics EPS beats by $0.21, beats on revenue [2/24/2021 7:06 AM]	95.52	11.24 (13.34%)	87.28	3.00 (3.56%)	23.81 - 96.54	3,701,087	1,570,523	5,866
Horizon Therapeutics EPS beats by $0.21, beats on revenue [2/24/2021 7:06 AM] Horizon Therapeutics Q4 2020 Earnings Preview [2/23/2021 11:19 AM] Horizon Therapeutics shares rise on strong Q4 beat, FY forecast [2/24/2021 10:19 AM] Horizon Therapeutics plc Reports Record Fourth-Quarter and Full-Year 2020 Financial Results; Announces Full-Year 2021 Guidance [Feb-24-21 07:00AM]
02-11-2020	PM	7:00 AM ET (Nov 2)	HZNP	Horizon Therapeutics Public Limited Company	17,130	1.74	1.00	0.64	Horizon Therapeutics EPS beats by $0.77, beats on revenue [11/2/2020 7:02 AM]	73.58	-1.36 (-1.81%)	72.50	-2.43 (-3.24%)	23.81 - 86.67	5,220,571	2,335,061	96,593

05-08-2020	PM	7:00 AM ET (Aug 5)	HZNP	Horizon Therapeutics Public Limited Company	11,990	0.43	0.40	0.49	Horizon Therapeutics EPS beats by $0.04, beats on revenue [8/5/2020 7:06 AM]	72.66	10.87 (17.59%)	73.71	11.92 (19.29%)	22.84 - 73.50	3,928,193	1,923,101	176,452

06-05-2020	PM		HZNP	Horizon Therapeutics Public Limited Company	6,900	0.44	0.23	0.30	Horizon Pharma EPS beats by $0.19, beats on revenue [5/6/2020 7:02 AM]	37.38	1.08 (2.99%)	41.99	4.61 (12.33%)	22.69 - 39.10	2,132,402	1,855,550	95,507